Answers are grounded in this paper and cite their sources.
Fenestrating adenocarcinoma is an emerging EWSR1::BEND2-associated malignancy of the pharyngeal region whose reported architectural diversity includes apparently biphasic arrangements, basal/squamoid differentiation and hyalinised pseudorosettes. These observations expose a specific diagnostic uncertainty: does apparent epithelial–myoepithelial organisation represent genuine neoplastic myoepithelial differentiation, or can it arise through basal/squamoid mimicry or incorporation of native glandular structures? The distinction remains unresolved because the published cases have not undergone a uniform, compartment-resolved assessment of cellular differentiation and neoplastic membership. This Perspective proposes a three-gate pathological framework separating anatomical compartment identification, differentiation assignment and molecular attribution of neoplastic identity. Four competing explanations are considered: genuine biphasic differentiation, basal/squamoid mimicry, non-neoplastic glandular entrapment and regional phenotypic heterogeneity. Serial-section morphology, spatially registered complementary immunohistochemistry and, where feasible, compartment-directed fusion analysis could discriminate among these possibilities. Neither p63/p40 expression nor individual negative myoepithelial markers independently determine lineage; similarly, a shared EWSR1::BEND2 fusion establishes molecular relatedness without proving differentiation. Reproducible demonstration of a distinct, fusion-associated abluminal population with coherent myoepithelial differentiation would challenge the proposed mimicry explanation. The immediate significance is diagnostic: apparent bilayering in a rare pharyngeal carcinoma must not automatically establish epithelial–myoepithelial carcinoma or another recognised biphasic neoplasm. The framework offers a falsifiable approach to refining tumour characterisation without prematurely modifying classification or clinical management.
No takes yet. Share an insight, caveat, or question.
Birupaksha Biswas (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: